1. Richardson P, McKenna W, Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definitionand Classification of cardiomyopathies. Circulation 1996. 93 (5): 841–42.
2. Philippe Kolh, Nicolas Danchin, C.Di Mario, Classification of cardiomyopathies, European Heart J 2008; 29 (2): 270–6.
3. Ferrari R, La Canno G, Giubbini R et al. Hibernating myocardium in patients with coronary artery disease: identification and clinical importance Cardiovasc. Drugs Thcr 1992; 6: 287–93.
4. Schuiz R, Hcuscli G. Characterization of hibernating and stunned myocardiiim, Enr Heart J 1995; 16 (2): 19–25.
5. Baker DW, Jones R, Hodges J. Management of heart failure, the role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 2004. 27 (2): 1528–34.
6. Allman KC, Shaw LJ, Hachamovitch R et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis, J Am Coll Cardiol 2002. 39: 1151–8.
7. Eagle KA, Guyton RA, Davidoff R et al. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: а report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 2004. 2: 214–311.
Авторы
А.Н.Самко, Е.В.Меркулов, В.М.Миронов, Д.Н.Филатов
ФГБУ Российский кардиологический научно-производственный комплекс Минздрава России, Москва